About the mRNA- Based Therapeutics Summit Europe
Successfully Design & Develop Next-Generation of mRNA- Based Vaccines & Therapeutics with Improved Specificity, Delivery & Efficacy for Immuno-Oncology, Infectious Diseases & Beyond
The dramatic success of mRNA- based vaccines has marked the beginning of what looks to be a limitless opportunity for mRNA- based therapeutics to disrupt the biopharma industry.
The mRNA- Based Therapeutics Summit Europe will leverage the experience from the first to market pioneers, as well as unveiling the strategies the next generation of drug developers, technology providers and academic teams are employing to accelerate successful discovery, translation and development of second-generation of mRNA- based vaccines and emerging therapeutics, unleashing the full potential of this transformative class of medicines.
Tailored to showcase the latest innovations and engage in discussions on the hottest topics facing the industry, join this exclusive community of mRNA, vaccine and therapeutics Directors, Heads and VPs in Berlin to network and learn from the leading experts in pharma, biotech and academia, as we discuss how to successfully translate and develop potent, scalable and effective mRNA- based therapies that address a plethora of disease indications.